VVOS logo

Vivos Therapeutics (VVOS) Enterprise Value

Enterprise Value

$10.80 M
-$1.94 M-15.19%

Wed, 12 Mar 2025 23:01:12 GMT


Summary


Performance

VVOS Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherVVOSvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

VVOS Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-15.2%-11.1%-11.1%
1 m1 month-26.4%-20.0%-20.0%
3 m3 months-36.8%-28.9%-28.9%
6 m6 months+125.4%+55.8%+9.6%
ytdytd-35.7%-27.9%-27.9%
1 y1 year+25.3%+87.1%-29.1%
5 y5 years---

VVOS Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-33.8%$9.84 M+9.8%
3 m3-month$26 M-58.0%$9.84 M+9.8%
6 m6-month$26 M-58.0%$4.76 M+126.8%
1 y1-year$26 M-58.0%$1.80 M+500.3%
3 y3-year$46 M-76.5%$1.80 M+500.3%
5 y5-year$163 M-93.4%$1.80 M+500.3%
alltimeall time$163 M-93.4%$1.80 M+500.3%

Vivos Therapeutics Enterprise Value History

DateValue
2025
$10.80 M(-35.7%)
2024
$16.80 M(-26.7%)
2023
$22.91 M(+181.3%)
DateValue
2022
$8.15 M(-72.3%)
2021
$29.38 M(-67.6%)
2020
$90.71 M

FAQ

  • What is Vivos Therapeutics enterprise value?
  • What is the all time high enterprise value for Vivos Therapeutics?
  • What is VVOS enterprise value year-to-date change?
  • What is Vivos Therapeutics enterprise value year-on-year change?

What is Vivos Therapeutics enterprise value?

The current enterprise value of VVOS is $10.80 M

What is the all time high enterprise value for Vivos Therapeutics?

Vivos Therapeutics all-time high enterprise value is $163.32 M

What is VVOS enterprise value year-to-date change?

Vivos Therapeutics enterprise value has changed by -$6.00 M (-35.69%) since the beginning of the year

What is Vivos Therapeutics enterprise value year-on-year change?

Over the past year, VVOS enterprise value has changed by +$2.18 M (+25.31%)